Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Apr 2001

Zöllner B, Feucht H H, Weitner L, Adam A, Schröter M, Schäfer P, Laufs R

Abstract excerpt

BACKGROUND: Resistance-associated mutations in HIV-1 evolve even under highly active antiretroviral therapy. OBJECTIVE: To evaluate the clinical efficacy of genotypic-resistance testing (GRT), to estimate the potential of a given antiretroviral therapy for prevention of further resistance mutations. STUDY DESIGN: Ten patients were treated prospectively with drugs, according to the results of a GRT. Five patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Decision Making

Share to Drug Resistance, Microbial

Share to HIV Infections

Share to Longitudinal Studies

Source

Identifiers

PMID: 11255096
DOI: 10.1016/s1386-6532(00)00183-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.PMID 11255096Read ↗

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Clinical utility of resistance testing: retrospective and prospective data supporting use and current recommendations.Semantic proximity Read ↗

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.Semantic proximity Read ↗

Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments.Semantic proximity Read ↗

Genotypic resistance tests in the management of the HIV-infected patient at virological failure.Semantic proximity Read ↗

A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigators.Semantic proximity Read ↗

[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].Semantic proximity Read ↗

A virological perspective on resistance in highly treatment-experienced patients.Semantic proximity Read ↗

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.Semantic proximity Read ↗

Will drug resistance testing prove reliable enough to enhance HIV treatments?Semantic proximity Read ↗

Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.Semantic proximity Read ↗

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.